188 related articles for article (PubMed ID: 9066665)
41. Immunomodulatory and antitumor activity of triterpenoid fractions from the rhizomes of Astilbe chinensis.
Tu J; Sun HX; Ye YP
J Ethnopharmacol; 2008 Sep; 119(2):266-71. PubMed ID: 18692123
[TBL] [Abstract][Full Text] [Related]
42. Antitumor activity of ZD1694 (tomudex) against human head and neck cancer in nude mouse models: role of dosing schedule and plasma thymidine.
Cao S; McGuire JJ; Rustum YM
Clin Cancer Res; 1999 Jul; 5(7):1925-34. PubMed ID: 10430100
[TBL] [Abstract][Full Text] [Related]
43. Anti-tumor action of alkyl-lysophospholipids (Review).
Berdel WE; Bausert WR; Fink U; Rastetter J; Munder PG
Anticancer Res; 1981; 1(6):345-52. PubMed ID: 7046622
[TBL] [Abstract][Full Text] [Related]
44. Cytotoxic and antitumor effect of a fraction from cell-free extract of group A Streptococcus on transplantable tumor cells.
Higuchi Y; Shoin S
Anticancer Res; 1987; 7(6):1251-6. PubMed ID: 3327452
[TBL] [Abstract][Full Text] [Related]
45. Himematsutake (Iwade Strain 101) extract (ABM-FD): genetic toxicology and a 3-month dietary toxicity study in rats.
Sumiya T; Ikeda Y; Broadmeadow A; May K; Pritchard L; Horne C; Burlinson B
Food Chem Toxicol; 2008 Jun; 46(6):1949-59. PubMed ID: 18353517
[TBL] [Abstract][Full Text] [Related]
46. Antitumor and apoptosis promoting properties of atorvastatin, an inhibitor of HMG-CoA reductase, against Dalton's Lymphoma Ascites tumor in mice.
Ajith TA; Anu V; Riji T
J Exp Ther Oncol; 2008; 7(4):291-8. PubMed ID: 19227009
[TBL] [Abstract][Full Text] [Related]
47. [Studies on the antitumor active polysaccharides from the mycelia of Poria cocos Wolf. III. Antitumor activity against mouse tumors].
Kanayama H; Togami M; Adachi N; Fukai Y; Okumoto T
Yakugaku Zasshi; 1986 Apr; 106(4):307-12. PubMed ID: 3735073
[No Abstract] [Full Text] [Related]
48. [Studies on the antitumor activity of traditional Chinese medicines. (II). The antitumor mechanism of traditional Chinese medicines].
Ito H; Shimura K
Gan To Kagaku Ryoho; 1985 Nov; 12(11):2149-54. PubMed ID: 4062314
[TBL] [Abstract][Full Text] [Related]
49. Maitake D-Fraction enhances antitumor effects and reduces immunosuppression by mitomycin-C in tumor-bearing mice.
Kodama N; Murata Y; Asakawa A; Inui A; Hayashi M; Sakai N; Nanba H
Nutrition; 2005 May; 21(5):624-9. PubMed ID: 15850970
[TBL] [Abstract][Full Text] [Related]
50. [Antitumor activity of chlorella extract, PCM-4, by oral administration].
Nomoto K; Yokokura T; Satoh H; Mutai M
Gan To Kagaku Ryoho; 1983 Mar; 10(3):781-5. PubMed ID: 6881997
[TBL] [Abstract][Full Text] [Related]
51. Optimization for the production of water-soluble polysaccharide from Pleurotus citrinopileatus in submerged culture and its antitumor effect.
Wang JC; Hu SH; Liang ZC; Yeh CJ
Appl Microbiol Biotechnol; 2005 Jun; 67(6):759-66. PubMed ID: 15703910
[TBL] [Abstract][Full Text] [Related]
52. [Studies on antitumor activity of rhEndostatin].
Li HY; Li Y; Liu ZH; Wu HJ; Chen FH; Chen XG
Yao Xue Xue Bao; 2002 Oct; 37(10):763-6. PubMed ID: 12567857
[TBL] [Abstract][Full Text] [Related]
53. Induction of antimicrobial activity by antitumor substances from pine cone extract of Pinus parviflora Sieb. et Zucc.
Harada H; Sakagami H; Konno K; Sato T; Osawa N; Fujimaki M; Komatsu N
Anticancer Res; 1988; 8(4):581-7. PubMed ID: 3052246
[TBL] [Abstract][Full Text] [Related]
54. Beta-glucan, a "specific" biologic response modifier that uses antibodies to target tumors for cytotoxic recognition by leukocyte complement receptor type 3 (CD11b/CD18).
Yan J; Vetvicka V; Xia Y; Coxon A; Carroll MC; Mayadas TN; Ross GD
J Immunol; 1999 Sep; 163(6):3045-52. PubMed ID: 10477568
[TBL] [Abstract][Full Text] [Related]
55. Marked antitumor activity of a new potent acronycine derivative in orthotopic models of human solid tumors.
Guilbaud N; Kraus-Berthier L; Meyer-Losic F; Malivet V; Chacun C; Jan M; Tillequin F; Michel S; Koch M; Pfeiffer B; Atassi G; Hickman J; Pierré A
Clin Cancer Res; 2001 Aug; 7(8):2573-80. PubMed ID: 11489841
[TBL] [Abstract][Full Text] [Related]
56. Ca2+-dependent, Fas- and perforin-independent apoptotic death of allografted tumor cells by a type of activated macrophage.
Yoshida R; Sanchez-Bueno A; Yamamoto N; Einaga-Naito K
J Immunol; 1997 Jul; 159(1):15-21. PubMed ID: 9200433
[TBL] [Abstract][Full Text] [Related]
57. Maltose tetrapalmitate, a nontoxic immunopotentiator with antitumor activity.
Nigam VN; Brailovsky CA; Chopra C
Cancer Res; 1978 Oct; 38(10):3315-21. PubMed ID: 688221
[TBL] [Abstract][Full Text] [Related]
58. Antitumor effects of (1-->3)-beta-D-glucan and (1-->6)-beta-D-glucan purified from newly cultivated mushroom, Hatakeshimeji (Lyophyllum decastes Sing.).
Ukawa Y; Ito H; Hisamatsu M
J Biosci Bioeng; 2000; 90(1):98-104. PubMed ID: 16232825
[TBL] [Abstract][Full Text] [Related]
59. Macrophage functions in beige (Chédiak-Higashi syndrome) mice.
Mahoney KH; Morse SS; Morahan PS
Cancer Res; 1980 Nov; 40(11):3934-9. PubMed ID: 7471044
[TBL] [Abstract][Full Text] [Related]
60. Increased macrophage activity in protein A treated tumor regressed animals.
Prasad AK; Singh KP; Saxena AK; Mathur NK; Ray PK
Immunopharmacol Immunotoxicol; 1987; 9(4):541-61. PubMed ID: 3437106
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
